michigan semaglutide gastroparesis lawsuit Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs OZEMPIC, WEGOVY, and RYBELUS LAWSUIT

What Makes Dual Agonists Unique in Obesity Treatment Dual agonists represent the next evolution in hormonal therapies for obesity

Less Common Side Effects: In rare cases, Rybelsus can lead to more serious conditions such as: Allergic responses (such as hives, swelling, or breathing difficulties) Pancreatitis (inflammation of the pancreas) Gallbladder disease Kidney problems Liver problems Heightened risk of hypoglycemia (low blood sugar) in individuals using insulin or other diabetes medications Hair loss Skin rash Rybelsus may cause hypoglycemia, or low blood sugar, particularly when its used in combination with other diabetes medications like insulin

Another major advantage of semaglutide is its dosing schedule

planned for offering once legally available Expected weight loss: Early trials suggest potent effects, but long-term data still emerging Administration: Once-weekly injection (investigational) Best for: Future option for carefully selected patients under close medical supervision Not sure which is right for you

This can stimulate fat burning and discourage fat storage, which may aid in weight loss